Micregen

News

Micregen Co-founder Barry Sharples Showcases Secretomix® Platform at Exclusive 2024 Longevity Investors Conference

Barry Sharples, our Executive Chairman and Co-founder, was one of 10 exclusive global speakers invited to pitch at the invite-only 2024 Longevity Investors Conference in Gstaad, Switzerland. This was...

Micregen to Sponsor 37th International Symposium on Pediatric Surgical Research 2024

Micregen is pleased to announce its sponsorship of the 37th International Symposium on Pediatrics Surgical Research 2024, to be held at the Karolinska Institute in Stockholm, Sweden. This conference...

We are delighted to be featured in Nature’s Pediatric Research Paper as an “Industry Partner” in the NEC-ACCELERATOR

  (NECrotizing Enterocolitis-ACceleration of CELl-based & Regenerative medicine Advancements for Translation in neOnates), enhancing the clinical translation of stem cell-based potential...

Micregen Co-Founder Prof. Paolo De Coppi Included in TIME Magazines 100 Most Influential People in Health

Micregen are very proud to announce that Prof. Paolo De Coppi, one of our Founding Scientists and Clinical Consultant, has been included as a global leading innovator in TIME Magazine...

Micregen Co-Founder, Prof. Paolo De Coppi is pushing boundaries in Stem Cell Research

One of Micregen’s Founders and Clinical Consultant, Prof. Paolo De Coppi, has been making the news recently. Having his work featured in some of the world’s leading Scientific...

Micregen Invited to Present “Down Under” in Melbourne at ISEV2024

Following the successful presentation last month in London at the “Advanced Therapies 2024 Conference”  which discussed Secretomix®’s ability to improve gut and lung structure...

We extend a warm and enthusiastic welcome to our newly appointed Managing Director

Today marks an exciting moment as we extend a warm and enthusiastic welcome to our newly appointed Managing Director, Dr Athanasios Papadopoulos. With a distinguished career, Dr Papadopoulos brings...

Micregen have won the UK Pharma Awards – Innovation of the Year!

Micregen have won the UK Pharma Awards – Innovation of the Year! Peer reviewed recognition when in the field of Longevity can only help build the life science industry interest in regenerative...